Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.
Identifieur interne : 000043 ( Main/Exploration ); précédent : 000042; suivant : 000044Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.
Auteurs : Gaetano Alfano [Italie] ; Francesco Fontana [Italie] ; Giovanni Guaraldi [Italie] ; Gianni Cappelli [Italie] ; Cristina Mussini [Italie]Source :
- International journal of STD & AIDS [ 1758-1052 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Débit de filtration glomérulaire (MeSH), Femelle (MeSH), Humains (MeSH), Immunomodulation (MeSH), Immunosuppression thérapeutique (MeSH), Infections opportunistes liées au SIDA (traitement médicamenteux), Infections opportunistes liées au SIDA (virologie), Infections à VIH (complications), Infections à VIH (immunologie), Infections à VIH (traitement médicamenteux), Infections à polyomavirus (diagnostic), Infections à polyomavirus (traitement médicamenteux), Infections à virus oncogènes (diagnostic), Infections à virus oncogènes (traitement médicamenteux), Léflunomide (usage thérapeutique), Numération des lymphocytes CD4 (MeSH), Pyélonéphrite (complications), Résultat thérapeutique (MeSH), Thérapie antirétrovirale hautement active (MeSH), Transplantation rénale (effets indésirables), Virus BK (isolement et purification).
- MESH :
- diagnostic : Infections à polyomavirus, Infections à virus oncogènes.
- effets indésirables : Infections à VIH, Pyélonéphrite, Transplantation rénale.
- immunologie : Infections à VIH.
- isolement et purification : Virus BK.
- traitement médicamenteux : Infections opportunistes liées au SIDA, Infections à VIH, Infections à polyomavirus, Infections à virus oncogènes.
- usage thérapeutique : Léflunomide.
- virologie : Infections opportunistes liées au SIDA.
- Adulte d'âge moyen, Débit de filtration glomérulaire, Femelle, Humains, Immunomodulation, Immunosuppression thérapeutique, Numération des lymphocytes CD4, Résultat thérapeutique, Thérapie antirétrovirale hautement active.
English descriptors
- KwdEn :
- AIDS-Related Opportunistic Infections (drug therapy), AIDS-Related Opportunistic Infections (virology), Antiretroviral Therapy, Highly Active (MeSH), BK Virus (isolation & purification), CD4 Lymphocyte Count (MeSH), Female (MeSH), Glomerular Filtration Rate (MeSH), HIV Infections (complications), HIV Infections (drug therapy), HIV Infections (immunology), Humans (MeSH), Immunomodulation (MeSH), Immunosuppression (MeSH), Kidney Transplantation (adverse effects), Leflunomide (therapeutic use), Middle Aged (MeSH), Polyomavirus Infections (diagnosis), Polyomavirus Infections (drug therapy), Pyelonephritis (complications), Treatment Outcome (MeSH), Tumor Virus Infections (diagnosis), Tumor Virus Infections (drug therapy).
- MESH :
- chemical , therapeutic use : Leflunomide.
- adverse effects : Kidney Transplantation.
- complications : HIV Infections, Pyelonephritis.
- diagnosis : Polyomavirus Infections, Tumor Virus Infections.
- drug therapy : AIDS-Related Opportunistic Infections, HIV Infections, Polyomavirus Infections, Tumor Virus Infections.
- immunology : HIV Infections.
- isolation & purification : BK Virus.
- virology : AIDS-Related Opportunistic Infections.
- Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Female, Glomerular Filtration Rate, Humans, Immunomodulation, Immunosuppression, Middle Aged, Treatment Outcome.
DOI: 10.1177/0956462419900853
PubMed: 32075537
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.</title><author><name sortKey="Alfano, Gaetano" sort="Alfano, Gaetano" uniqKey="Alfano G" first="Gaetano" last="Alfano">Gaetano Alfano</name><affiliation wicri:level="1"><nlm:affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Fontana, Francesco" sort="Fontana, Francesco" uniqKey="Fontana F" first="Francesco" last="Fontana">Francesco Fontana</name><affiliation wicri:level="1"><nlm:affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Guaraldi, Giovanni" sort="Guaraldi, Giovanni" uniqKey="Guaraldi G" first="Giovanni" last="Guaraldi">Giovanni Guaraldi</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Cappelli, Gianni" sort="Cappelli, Gianni" uniqKey="Cappelli G" first="Gianni" last="Cappelli">Gianni Cappelli</name><affiliation wicri:level="1"><nlm:affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Mussini, Cristina" sort="Mussini, Cristina" uniqKey="Mussini C" first="Cristina" last="Mussini">Cristina Mussini</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32075537</idno><idno type="pmid">32075537</idno><idno type="doi">10.1177/0956462419900853</idno><idno type="wicri:Area/Main/Corpus">000117</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000117</idno><idno type="wicri:Area/Main/Curation">000117</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000117</idno><idno type="wicri:Area/Main/Exploration">000117</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.</title><author><name sortKey="Alfano, Gaetano" sort="Alfano, Gaetano" uniqKey="Alfano G" first="Gaetano" last="Alfano">Gaetano Alfano</name><affiliation wicri:level="1"><nlm:affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Fontana, Francesco" sort="Fontana, Francesco" uniqKey="Fontana F" first="Francesco" last="Fontana">Francesco Fontana</name><affiliation wicri:level="1"><nlm:affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Guaraldi, Giovanni" sort="Guaraldi, Giovanni" uniqKey="Guaraldi G" first="Giovanni" last="Guaraldi">Giovanni Guaraldi</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Cappelli, Gianni" sort="Cappelli, Gianni" uniqKey="Cappelli G" first="Gianni" last="Cappelli">Gianni Cappelli</name><affiliation wicri:level="1"><nlm:affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Mussini, Cristina" sort="Mussini, Cristina" uniqKey="Mussini C" first="Cristina" last="Mussini">Cristina Mussini</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author></analytic><series><title level="j">International journal of STD & AIDS</title><idno type="eISSN">1758-1052</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Opportunistic Infections (drug therapy)</term><term>AIDS-Related Opportunistic Infections (virology)</term><term>Antiretroviral Therapy, Highly Active (MeSH)</term><term>BK Virus (isolation & purification)</term><term>CD4 Lymphocyte Count (MeSH)</term><term>Female (MeSH)</term><term>Glomerular Filtration Rate (MeSH)</term><term>HIV Infections (complications)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (immunology)</term><term>Humans (MeSH)</term><term>Immunomodulation (MeSH)</term><term>Immunosuppression (MeSH)</term><term>Kidney Transplantation (adverse effects)</term><term>Leflunomide (therapeutic use)</term><term>Middle Aged (MeSH)</term><term>Polyomavirus Infections (diagnosis)</term><term>Polyomavirus Infections (drug therapy)</term><term>Pyelonephritis (complications)</term><term>Treatment Outcome (MeSH)</term><term>Tumor Virus Infections (diagnosis)</term><term>Tumor Virus Infections (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Débit de filtration glomérulaire (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Immunomodulation (MeSH)</term><term>Immunosuppression thérapeutique (MeSH)</term><term>Infections opportunistes liées au SIDA (traitement médicamenteux)</term><term>Infections opportunistes liées au SIDA (virologie)</term><term>Infections à VIH (complications)</term><term>Infections à VIH (immunologie)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à polyomavirus (diagnostic)</term><term>Infections à polyomavirus (traitement médicamenteux)</term><term>Infections à virus oncogènes (diagnostic)</term><term>Infections à virus oncogènes (traitement médicamenteux)</term><term>Léflunomide (usage thérapeutique)</term><term>Numération des lymphocytes CD4 (MeSH)</term><term>Pyélonéphrite (complications)</term><term>Résultat thérapeutique (MeSH)</term><term>Thérapie antirétrovirale hautement active (MeSH)</term><term>Transplantation rénale (effets indésirables)</term><term>Virus BK (isolement et purification)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Leflunomide</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Kidney Transplantation</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term><term>Pyelonephritis</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Polyomavirus Infections</term><term>Tumor Virus Infections</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à polyomavirus</term><term>Infections à virus oncogènes</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>HIV Infections</term><term>Polyomavirus Infections</term><term>Tumor Virus Infections</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Infections à VIH</term><term>Pyélonéphrite</term><term>Transplantation rénale</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>BK Virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus BK</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term><term>Infections à VIH</term><term>Infections à polyomavirus</term><term>Infections à virus oncogènes</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Léflunomide</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term><term>CD4 Lymphocyte Count</term><term>Female</term><term>Glomerular Filtration Rate</term><term>Humans</term><term>Immunomodulation</term><term>Immunosuppression</term><term>Middle Aged</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Débit de filtration glomérulaire</term><term>Femelle</term><term>Humains</term><term>Immunomodulation</term><term>Immunosuppression thérapeutique</term><term>Numération des lymphocytes CD4</term><term>Résultat thérapeutique</term><term>Thérapie antirétrovirale hautement active</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32075537</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1758-1052</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>03</Month></PubDate></JournalIssue><Title>International journal of STD & AIDS</Title><ISOAbbreviation>Int J STD AIDS</ISOAbbreviation></Journal><ArticleTitle>Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.</ArticleTitle><Pagination><MedlinePgn>387-391</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0956462419900853</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alfano</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0591-8622</Identifier><AffiliationInfo><Affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guaraldi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelli</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mussini</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinic of Infectious Diseases, University of Modena and Reggio Emilia, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J STD AIDS</MedlineTA><NlmUniqueID>9007917</NlmUniqueID><ISSNLinking>0956-4624</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>G162GK9U4W</RegistryNumber><NameOfSubstance UI="D000077339">Leflunomide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017088" MajorTopicYN="N">AIDS-Related Opportunistic Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023241" MajorTopicYN="Y">Antiretroviral Therapy, Highly Active</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001739" MajorTopicYN="N">BK Virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056747" MajorTopicYN="N">Immunomodulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007165" MajorTopicYN="Y">Immunosuppression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="N">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077339" MajorTopicYN="N">Leflunomide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D027601" MajorTopicYN="N">Polyomavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011704" MajorTopicYN="N">Pyelonephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014412" MajorTopicYN="N">Tumor Virus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">BK virus</Keyword><Keyword MajorTopicYN="Y">HIV</Keyword><Keyword MajorTopicYN="Y">antiretroviral therapy</Keyword><Keyword MajorTopicYN="Y">kidney transplantation</Keyword><Keyword MajorTopicYN="Y">mTORi</Keyword><Keyword MajorTopicYN="Y">rapamycin</Keyword><Keyword MajorTopicYN="Y">sirolimus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32075537</ArticleId><ArticleId IdType="doi">10.1177/0956462419900853</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Alfano, Gaetano" sort="Alfano, Gaetano" uniqKey="Alfano G" first="Gaetano" last="Alfano">Gaetano Alfano</name></noRegion><name sortKey="Alfano, Gaetano" sort="Alfano, Gaetano" uniqKey="Alfano G" first="Gaetano" last="Alfano">Gaetano Alfano</name><name sortKey="Cappelli, Gianni" sort="Cappelli, Gianni" uniqKey="Cappelli G" first="Gianni" last="Cappelli">Gianni Cappelli</name><name sortKey="Cappelli, Gianni" sort="Cappelli, Gianni" uniqKey="Cappelli G" first="Gianni" last="Cappelli">Gianni Cappelli</name><name sortKey="Fontana, Francesco" sort="Fontana, Francesco" uniqKey="Fontana F" first="Francesco" last="Fontana">Francesco Fontana</name><name sortKey="Guaraldi, Giovanni" sort="Guaraldi, Giovanni" uniqKey="Guaraldi G" first="Giovanni" last="Guaraldi">Giovanni Guaraldi</name><name sortKey="Mussini, Cristina" sort="Mussini, Cristina" uniqKey="Mussini C" first="Cristina" last="Mussini">Cristina Mussini</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000043 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000043 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= RapamycinFungusV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32075537
|texte= Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32075537" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a RapamycinFungusV1
| This area was generated with Dilib version V0.6.38. |  |